Karyopharm Therapeutics: Q1 Earnings Snapshot

NEWTON, Mass. (AP) — NEWTON, Mass. (AP) — Karyopharm Therapeutics Inc. (KPTI) on Thursday reported a loss of $34.1 million in its first quarter.

The Newton, Massachusetts-based company said it had a loss of 30 cents per share.

The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 34 cents per share.

The pharmaceutical company posted revenue of $38.7 million in the period, also beating Street forecasts. Seven analysts surveyed by Zacks expected $37.9 million.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KPTI at https://www.zacks.com/ap/KPTI

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up